169 search results for: Pathophysiology

ERS-ISIAN 2023 | From Endotype to Phenotype: Linking <b>Pathophysiology</b> to Burden and Clinical Management for Patients with Uncontrolled and/or Severe CRSwNP
Rhinology
ERS-ISIAN 2023 | From Endotype to Phenotype: Linking Pathophysiology to Burden and Clinical Management for Patients with Uncontrolled and/or Severe CRSwNP
expert video

Prof. Peter Hellings discusses the interconnection between the pathophysiology, burden and clinical management of uncontrolled and/or severe CRSwNP

View more
The <b>Pathophysiology</b> of Prurigo Nodularis
Dermatology
The Pathophysiology of Prurigo Nodularis
videoanimation

An infographic exploring the pathophysiology of prurigo nodularis and the role of type 2 inflammation.

View more
A brief overview of the <b>pathophysiology</b> of PN
Dermatology
A brief overview of the pathophysiology of PN
expert video

Dr. Chovatiya explains that PN is primarily a chronic itch disease with a complex pathophysiology involving neuronal changes, type 2 inflammation, and fibrotic skin processes, affecting patients' overall well-being.

View more
The Role of IL-4 and IL-13 in the <b>Pathophysiology</b> of CSU
Dermatology
The Role of IL-4 and IL-13 in the Pathophysiology of CSU
expert video

Dr. Jason Hawkes details the role of IL-4 and IL-13 in the pathophysiology of CSU at EADV 2025

View more
Epidemiology and <b>Pathophysiology</b> of AD in Children
Dermatology
Epidemiology and Pathophysiology of AD in Children
expert video

In this expert interview video focusing on topics from the October 2024 ADVENT symposium at EAPS in Vienna, Austria, Dr Christine Bangert discusses the epidemiology of AD in children and the role of type 2 cytokines in driving the pathophysiology of the disease

View more
Understanding IL-33: A Key Factor in COPD Pathogenesis
Pulmonology
Understanding IL-33: A Key Factor in COPD Pathogenesis
interactivity

Explore the role of interleukin (IL)-33 in chronic obstructive pulmonary disease (COPD) pathophysiology and its potential as a therapeutic target.

View more
Event Page Thumbnail
Congress
27
April
2026
Congress
ADVENT at CEORL-HNS 2026

Join Sanofi and Regeneron for an educational symposium on type 2 inflammation, patient characteristics predictive of disease recurrence, and emerging real-world evidence for biologics in CRSwNP.

Potential Biomarkers of Subclinical Control in AD <b>Pathophysiology</b>
Dermatology
Potential Biomarkers of Subclinical Control in AD Pathophysiology
expert video

Dr. Amy Paller describes potential biomarkers of subclinical control at EADV 2025

View more
Screen depicting a mucus plug in the airways
Pulmonology
A view into the Airway: The Pathophysiology and Clinical Relevance of Mucus Plugs in Asthma
videoanimation

Explore the role of type 2 inflammation in the production of mucus plugs in asthma and the effects these plugs can have on patients.

View more
ATS 2024 | Type 2 Inflammation in the <b>Pathophysiology</b> of Asthma and COPD: What Is It and How Does It Impact Patients?
Pulmonology
ATS 2024 | Type 2 Inflammation in the Pathophysiology of Asthma and COPD: What Is It and How Does It Impact Patients?
expert video

Join leading experts for an educational symposium where they delve into the clinical consequences and real-world patient burden of type 2 inflammation in asthma and COPD.

View more
ERS 2024 | Understanding the Complex <b>Pathophysiology</b> of COPD
Pulmonology
ERS 2024 | Understanding the Complex Pathophysiology of COPD
expert video

Professor Klaus Rabe delves into the intricate inflammatory pathways and cellular mechanisms that drive the development and progression of COPD.

View more